Australia markets open in 9 hours 1 minute

Cisen Pharmaceutical Co., Ltd. (603367.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
15.49+0.25 (+1.64%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,364,111
4,066,088
3,782,593
3,674,158
Cost of revenue
1,901,971
1,789,293
1,684,647
1,570,901
Gross profit
2,462,140
2,276,796
2,097,946
2,103,257
Operating expenses
Research development
348,710
335,169
334,346
309,585
Selling general and administrative
1,456,706
1,391,131
1,316,658
1,238,373
Total operating expenses
1,998,051
1,918,927
1,811,533
1,681,011
Operating income or loss
464,090
357,868
286,413
422,246
Interest expense
6,066
4,295
6,097
9,800
Income before tax
486,595
366,191
336,132
484,516
Income tax expense
25,542
13,806
2,230
47,156
Income from continuing operations
461,053
352,386
333,902
437,360
Net income
448,190
350,073
334,146
438,784
Net income available to common shareholders
448,190
350,073
334,146
438,784
Basic EPS
0.99
0.77
0.74
0.97
Diluted EPS
0.99
0.77
0.74
0.97
Basic average shares
452,572
454,640
451,549
452,355
Diluted average shares
452,572
454,640
451,549
452,355